GGrantIndex
← Leaderboards

Andre Venot

University Of Georgia (Uga)

$135,675
Attributed
$135,675
Total exposure
79
Grants
73
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $35.4K · FY200511
$50K$37.5K$25K$12.5K$0
'05
'06
'07
'08
'09
'10
'11

Funding mix

By agency

NIH$135,675 · 79

By mechanism

P41$135,675 · 79

Top collaborators

No co-investigators on record.

Most similar at University Of Georgia (Uga)

Same institution · by research overlap

Others in their field

Top investigators on “Resources

Research focus

ResourcesSourceFundingUnited States National Institutes Of HealthGrantInstitutionResearch PersonnelComputer Retrieval Of Information On Scientific Projects DatabaseNational Center For Research ResourcesPrincipal InvestigatorCostResearch InfrastructureAntibodiesGlycopeptidesAlkynesBiotinTechnology /Technique DevelopmentLabelPeptide SynthesisCarbonatesReactionMonoclonal AntibodiesThreoninePeptidoglycan

Grant awards (79)

2-NAPHTHALENEMETHANOL-?-D-XYLOPYRANOSIDE$1,772
P41 · FY2011 · RR · contact PI
DECAHYDRO 2-NAPHTHOL ?-D-XYLOPYRANOSIDE$1,772
P41 · FY2011 · RR · contact PI
TWO TETRASACCHARIDES$1,772
P41 · FY2011 · RR · contact PI
THREE MONOCLONAL O-GLCNAC ANTIBODIES$1,772
P41 · FY2011 · RR · contact PI
THREE GLYCOPEPTIDES$1,772
P41 · FY2011 · RR · contact PI
THREE MONOCLONAL O-GLCNAC ANTIBODIES$1,772
P41 · FY2011 · RR · contact PI
THREE MONOCLONAL O-GLCNAC ANTIBODIES$1,772
P41 · FY2011 · RR · contact PI
TWELVE TETRASACCHARIDES$1,772
P41 · FY2011 · RR · contact PI
THREE MONOCLONAL O-GLCNAC ANTIBODIES$1,772
P41 · FY2011 · RR · contact PI
THREE MONOCLONAL O-GLCNAC ANTIBODIES$1,772
P41 · FY2011 · RR · contact PI
THREE MONOCLONAL O-GLCNAC ANTIBODIES$1,772
P41 · FY2011 · RR · contact PI
MONOCLONAL O-GLCNAC ANTIBODY$1,772
P41 · FY2011 · RR · contact PI
THREE MONOCLONAL O-GLCNAC ANTIBODIES$1,772
P41 · FY2011 · RR · contact PI
THREE MONOCLONAL O-GLCNAC ANTIBODIES$1,772
P41 · FY2011 · RR · contact PI
THREE MONOCLONAL O-GLCNAC ANTIBODIES$1,772
P41 · FY2011 · RR · contact PI
THREE MONOCLONAL O-GLCNAC ANTIBODIES$1,772
P41 · FY2011 · RR · contact PI
THREE MONOCLONAL O-GLCNAC ANTIBODIES$1,772
P41 · FY2011 · RR · contact PI
N-(2,3,4,6-TETRA-O-ACETYL-?-D-MANNOPYRANOSYL)$1,772
P41 · FY2011 · RR · contact PI
TWO PEPTIDOGLYCAN DERIVATIVES$1,772
P41 · FY2011 · RR · contact PI
ALKYNE NITROPHENYL CARBONATE$1,772
P41 · FY2011 · RR · contact PI
EIGHT COMPOUNDS FOR CELL LABELING$1,685
P41 · FY2010 · RR · contact PI
FOUR SERUM VACCINATION SAMPLES$1,685
P41 · FY2010 · RR · contact PI
TERMINAL ALKYNE$1,685
P41 · FY2010 · RR · contact PI
BSA-MI-4" HNAC$1,685
P41 · FY2010 · RR · contact PI
FMOC ?-D-GAL(OAC)4 TYR-OH AND FMOC ?-D-GLANAC(OAC)3 ASN-OH$1,685
P41 · FY2010 · RR · contact PI
LIPOSOME PREPARATIONS$1,685
P41 · FY2010 · RR · contact PI
FMOC ?-D-GAL(OAC)3 SER ?OH$1,685
P41 · FY2010 · RR · contact PI
MDP-RHODAMINE$1,685
P41 · FY2010 · RR · contact PI
30 SERUM VACCINATION SAMPLES$1,685
P41 · FY2010 · RR · contact PI
FOUR PEPTIDOGLYCAN DERIVATIVES$1,685
P41 · FY2010 · RR · contact PI
FIVE PEPTIDES/GLYCOPEPTIDES:$1,685
P41 · FY2010 · RR · contact PI
FMOC ?-D-GLCNAC(OAC)3 SER-OH$1,685
P41 · FY2010 · RR · contact PI
INTERMEDIATES OF HEPARIN SULFATE DERIVATIVES (12)$1,685
P41 · FY2010 · RR · contact PI
TWELVE HEPARIN SULFATE DERIVATIVES$1,685
P41 · FY2010 · RR · contact PI
S-LINKED ALPHA1-6 MANNOBIOSE$1,685
P41 · FY2010 · RR · contact PI
MTRP-LYS (ACID), 50 ?L 10 MM AND MTRP-DAP (ACID/ACID), 735 ?L 272 MM$1,685
P41 · FY2010 · RR · contact PI
TWO O-GLCNAC SPECIFIC MONOCLONAL ANTIBODIES$1,685
P41 · FY2010 · RR · contact PI
?-D-GLCA-(1-4)-?-D-GLCNS6S-(1-4)-?-L-IDOA2S-(1-4)-?-D-GLCNS6S-AMINOPENTYL$1,685
P41 · FY2010 · RR · contact PI
2-NAPHTHALENEMETHANOL-?-D-XYLOPYRANOSIDE$1,685
P41 · FY2010 · RR · contact PI
ALKYNE NITROPHENYL CARBONATE$1,685
P41 · FY2010 · RR · contact PI
SYNTHESIS OF FMOC - BETA-D-GLCNAC-L-ASPARAGINE$2,193
P41 · FY2009 · RR · contact PI
SYNTHESIS OF FOUR LIPID A DERIVATIVES$2,193
P41 · FY2009 · RR · contact PI
FOURTEEN DIFFERENT MANNOSIDASES$2,193
P41 · FY2009 · RR · contact PI
THREE O-GLCNAC SPECIFIC MONOCLONAL ANTIBODIES 18B10C7 (3), 100 UL EACH$2,193
P41 · FY2009 · RR · contact PI
FLUORESCENT-LABELED ALKYNE$2,193
P41 · FY2009 · RR · contact PI
THREE O-GLCNAC SPECIFIC MONOCLONAL ANTIBODIES$2,193
P41 · FY2009 · RR · contact PI
BIOTIN-MODIFIED ALKYNE AND FLUORESCENT-LABELED ALKYNE$2,193
P41 · FY2009 · RR · contact PI
THREE O-GLCNAC MONOCLONAL ANTIBODIES 18B10C7(3)$2,193
P41 · FY2009 · RR · contact PI
FOUR THIO-LINKED MANNOSIDES$2,193
P41 · FY2009 · RR · contact PI
FITC- AND BIOTIN-LABELED ANTHRAX TRISACCHARIDE$2,193
P41 · FY2009 · RR · contact PI
BIOTIN-MODIFIED ALKYNE$2,193
P41 · FY2009 · RR · contact PI
BIOTIN-MODIFIED ALKYNE$2,193
P41 · FY2009 · RR · contact PI
MDP LABELED WITH RHODAMINE$2,193
P41 · FY2009 · RR · contact PI
BIOTIN DERIVATIVE, ALKYNE ALCOHOL AND ALKYNE NITROPHENYL CARBONATE$2,193
P41 · FY2009 · RR · contact PI
FMOC-BETA-D-GAL-L-SERINE$2,193
P41 · FY2009 · RR · contact PI
SYNTHESIS OF GLYCOPEPTIDE BUILDING BLOCKS$1,404
P41 · FY2008 · RR · contact PI
SYNTHESIS OF GLYCOPEPTIDE BUILDING BLOCKS$1,404
P41 · FY2008 · RR · contact PI
SYNTHESIS OF GLYCOPEPTIDE BUILDING BLOCKS$1,404
P41 · FY2008 · RR · contact PI
B-D-GALACTOPYRANOSIDE-2-NAPHTHALENEMETHANOL 103G$1,404
P41 · FY2008 · RR · contact PI
INFLUENZA INHIBITORS, 8 COMPOUNDS$1,404
P41 · FY2008 · RR · contact PI
SYNTHESIS OF FRAGMENTS OF FROM STREPTOCOCCUS PNEUMONIAE$1,404
P41 · FY2008 · RR · contact PI
SYNTHESIS OF GLYCOPEPTIDE BUILDING BLOCKS$1,404
P41 · FY2008 · RR · contact PI
1,6-ANHYDRO MANNOPYRANOSE$1,411
P41 · FY2007 · RR · contact PI
SYNTHESIS OF SPIN-LABELED ANALOGS$1,411
P41 · FY2007 · RR · contact PI
SYNTHESIS OF GLYCOPEPTIDES$1,411
P41 · FY2007 · RR · contact PI
SYNTHESIS OF GLYCOPEPTIDES$1,411
P41 · FY2007 · RR · contact PI
SYNTHESIS OF GLYCOPEPTIDES$1,411
P41 · FY2007 · RR · contact PI
1,6-ANHYDRO GLUCOPYRANOSE$1,411
P41 · FY2007 · RR · contact PI
SYNTHESIS OF SUGAR-NUCLEOTIDE ANALOG$1,430
P41 · FY2006 · RR · contact PI
SYNTHESIS OF SPIN-LABELED ANALOGS$1,430
P41 · FY2006 · RR · contact PI
SYNTHESIS OF KINASE INHIBITOR$1,430
P41 · FY2006 · RR · contact PI
SYNTHESIS OF SPIN-LABELED ANALOGS OF SUGAR NUCLEOTIDES$1,430
P41 · FY2006 · RR · contact PI
SYNTHESIS OF TRISACCHARIDE GLYCOPEPTIDE$1,430
P41 · FY2006 · RR · contact PI
SYNTHESIS OF MEMBRANE ASSOCIATING OLIGOSACCHARIDES$1,366
P41 · FY2005 · RR
SYNTHESIS OF SPIN-LABELED ANALOGS OF SUGAR NUCLEOTIDES$1,366
P41 · FY2005 · RR
SYNTHESIS OF TRI-SUBSTITUTED PURINE DERIVATIVES$1,366
P41 · FY2005 · RR
SYNTHESIS OF GLYCOPEPTIDES$1,366
P41 · FY2005 · RR
SYNTHESIS OF LIPID BASED CHEMOATTRACTANTS$1,366
P41 · FY2005 · RR
SYNTHESIS OF FLUORNATED GLYCOSYL TRANSFERASE DONORS$1,366
P41 · FY2005 · RR